News | September 09, 2013

Loma Linda University Medical Center Explores New Frontiers in Proton Therapy

Nation’s First Hospital-Based Proton Therapy Center Takes Lead in Developing More Precise Proton Scanning Beam

September 9, 2013 — More than two decades after becoming the world’s first hospital-based proton therapy center, the engineers, scientists and physicians at Loma Linda University Medical Center (LLUMC) continue to develop new technologies that will lead to the next generation of proton therapy treatment.

Because of its pinpoint accuracy, proton therapy today is a highly effective form of treatment for two main reasons: one, there is significantly less radiation to surrounding healthy tissues; and two, it has the ability to take care of many types of tumors found in adults and children often considered difficult to treat with standard radiation therapies.

“One might think that all proton beams are created equal, but that’s not the case,” said Jerry D. Slater, M.D., chairman of the LLUMC Proton Treatment & Research Center. “Scatter beam technology was the first type of technology we developed, and we still consider it the most effective proton therapy beam available for many types of tumors. But as far back as 1985, we were looking at active beam scanning (ABS) technology for use at LLUMC to provide another tool for oncologists to use to maximize treatment benefits.”

As a leader in proton beam development, LLUMC’s research is committed to creating the most effective proton delivery methods. As such, LLUMC has spent considerable time and resources studying the potential of ABS technology and has developed a scanning-beam delivery system with superior resolution and spot size. LLUMC’s ABS technology provides our physicians with a tool to irradiate complex tumors with superior conformity and without the need for an aperture. When the technology is approved for use at LLUMC, the proton treatment center will be able to offer the patient a completely personalized treatment using either ABS or scatter beam technology combined with the experience that comes from being the first hospital-based proton center.

“Our research is showing the promise of ABS technology specifically for certain large and irregularly shaped tumor sites. But for certain smaller-scale targets, the scatter beam could still be the most effective treatment option for patients,” Slater said. As a consequence, doctors anticipate that the scatter beam will be utilized to deliver the necessary radiation approximately 70-85 percent of the time.

“As we have done throughout our history, we will continue to search for new frontiers in proton therapy and through clinical research bring the best of what we’ve learned to our patients in a safe and efficient way,” said Slater.

For more information, visit:

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation
News | Proton Therapy | May 02, 2019
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment...
Pencil Beam Scanning Better Protects Children With Brain Tumors
News | Proton Therapy | May 01, 2019
A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Videos | Proton Therapy | March 01, 2019
ITN Associate Editor Jeff Zagoudis speaks with Mark Pankuch, Ph.D., director of physics and dosimetry at the...
Videos | Proton Therapy | February 28, 2019
ITN Associate Editor Jeff Zagoudis speaks with ...